Evidence map›Paper›PMID 16905695›Full record

Trial reportGut2006

A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.

P Sharma, S Wani, A P Weston, A Bansal, M Hall, S Mathur, A Prasad, R E Sampliner

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Gut, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Treatment for Barrett's oesophagus.The Cochrane database of systematic reviews · 2010
    Pooled it
  5. Pooled it
  6. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2010
    Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Role of endoscopy in early oesophageal cancer.Nature reviews. Gastroenterology & hepatology · 2016
    Review
  15. Article
  16. Article
  17. Article
  18. Endoscopic assessment and management of early esophageal adenocarcinoma.World journal of gastrointestinal oncology · 2014
    Review
  19. Management controversies in Barrett's oesophagus.Journal of gastroenterology · 2014
    Review
  20. Ablative therapies for Barrett's esophagus.Current gastroenterology reports · 2011
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

P SharmaUniversity of Kansas School of Medicine and Veterans Affairs Medical Center, Kansas City, MO 64128-2295, USA. psharma@kumc.edu
S Wani
A P Weston
A Bansal
M Hall
S Mathur
A Prasad
R E Sampliner
Southern Arizona VA Health Care System · USKansas City VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany modalities have been used to ablate Barrett's oesophagus (BO). However, long term results and comparative effectiveness are unknown.

aimsOur aim was to compare the long term efficacy of achieving complete reversal (endoscopic and histological) between multipolar electrocoagulation (MPEC) and argon plasma coagulation (APC) in BO patients and assess factors influencing successful ablation.

methodsPatients with BO, 2-6 cm long, underwent 24 hour pH testing on proton pump inhibitor (PPI) therapy. Patients were then randomised by BO length to undergo ablation with MPEC or APC every 4-8 weeks until endoscopic reversal or maximal of six treatment sessions.

resultsThirty five BO patients have been followed for at least two years following endoscopic ablation, 16 treated with MPEC and 19 with APC. There was complete reversal of BO in 24 patients (69%); 75% with MPEC and 63% with APC (p = 0.49). There was no difference in the number of sessions required in the two groups. There was no difference in age, pH results, BO length, PPI dose, or hiatal hernia size between patients with and without complete reversal. One patient developed an oesophageal stricture but there were no major complications such as bleeding or perforation.

conclusionsIn BO patients treated with MPEC or APC in combination with acid suppression, at long term follow up, complete reversal of BO can be maintained in approximately 70% of patients, irrespective of the technique. There are no predictors associated with achieving complete reversal of BO. Continued surveillance is still indicated in the post ablative setting. As yet, these techniques are not ready for clinical application (other than for high grade dysplasia or early oesophageal adenocarcinoma) and cannot be offered outside the research arena.

Indexed as

AdultAgedAged, 80 and overAntacidsBarrett EsophagusCombined Modality TherapyElectrocoagulationEsophageal NeoplasmsEsophagoscopyFemaleFollow-Up StudiesHumansHydrogen-Ion ConcentrationLaser CoagulationMaleMiddle AgedAntacidsProton Pump Inhibitors

Identifiers

PMID16905695
PMCPMC1860010
OpenAlexW2130939549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.